{"disease":{"id":"glioblastoma-multiforme-adult","name":"glioblastoma multiforme adult"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06146738","title":"The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)","phase":"","overall_status":"RECRUITING","enrollment_count":1015,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT06118723","title":"The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)","phase":"","overall_status":"RECRUITING","enrollment_count":784,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT06146725","title":"The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)","phase":"","overall_status":"RECRUITING","enrollment_count":564,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT06283927","title":"The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)","phase":"","overall_status":"RECRUITING","enrollment_count":464,"lead_sponsor_name":"Jasper Gerritsen","has_results":false},{"nct_id":"NCT05271240","title":"Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":432,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT04762069","title":"A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":252,"lead_sponsor_name":"CNS Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06273176","title":"The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma","phase":"","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06954636","title":"Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Sied Kebir","has_results":false},{"nct_id":"NCT05671016","title":"Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Brighton and Sussex University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT06781372","title":"Patient's Derived Organoids for Drug Screening in Glioblastoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03025893","title":"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT05653622","title":"Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Centre Paul Strauss","has_results":false},{"nct_id":"NCT05720078","title":"UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05565521","title":"UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05954858","title":"Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06496971","title":"A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"NaviFUS Corporation","has_results":false},{"nct_id":"NCT04469699","title":"Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"University Hospital Muenster","has_results":false},{"nct_id":"NCT05333588","title":"The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Hebei Senlang Biotechnology Inc., Ltd.","has_results":false},{"nct_id":"NCT03665545","title":"Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT05052957","title":"hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Leland Metheny","has_results":false},{"nct_id":"NCT06845020","title":"CSF Proteomic Characterization of Glioblastomas","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Univeridad Autonoma de Guadalajara","has_results":false},{"nct_id":"NCT04610229","title":"Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Azienda USL Reggio Emilia - IRCCS","has_results":false},{"nct_id":"NCT05977738","title":"Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"C.Dirven","has_results":false},{"nct_id":"NCT03075514","title":"Ketogenic Diets as an Adjuvant Therapy in Glioblastoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT04825275","title":"Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":true},{"nct_id":"NCT04869449","title":"Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}